ML24061A227: Difference between revisions
StriderTol (talk | contribs) (StriderTol Bot change) |
StriderTol (talk | contribs) (StriderTol Bot change) |
||
| Line 17: | Line 17: | ||
=Text= | =Text= | ||
{{#Wiki_filter:[7590-01-P] | {{#Wiki_filter:[7590-01-P] | ||
NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice AGENCY: U.S. Nuclear Regulatory Commission ACTION: Notice of Meeting. | |||
NUCLEAR REGULATORY COMMISSION | |||
Advisory Committee on the Medical Uses of Isotopes: Meeting Notice | |||
AGENCY: U.S. Nuclear Regulatory Commission | |||
ACTION: Notice of Meeting. | |||
==SUMMARY== | ==SUMMARY== | ||
: The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the | : The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April 8 - 9, 2024. A sample of agenda items to be discussed include: a review of recent medical events; a review of prescription error reduction methods; and a review of several NRC draft licensing guidance documents for the Eye90 microsphere device, the Akesis Galaxy RTi unit, and the LV Liberty Vision Y-90 episcleral brachytherapy source. The agenda is subject to change. The current agenda and any updates will be available on the ACMUIs Meetings and Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html or by e-mailing Ms. L. Armstead at the contact information below. | ||
Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April 8 - 9, 2024. A sample of | |||
agenda items to be discussed include: a review of recent medical events; a review of | |||
prescription error reduction methods; and a review of several NRC draft licensing guidance | |||
documents for the Eye90 microsphere device, the Akesis Galaxy RTi unit, and the LV Liberty | |||
Vision Y-90 episcleral brachytherapy source. The agenda is subject to change. The current | |||
agenda and any updates will be available on the ACMUIs Meetings and Related Documents | |||
web page at https://www.nrc.gov/reading-rm/doc- | |||
mailing Ms. L. Armstead at the contact information below. | |||
==Purpose:== | ==Purpose:== | ||
Discuss issues related to 10 CFR Part 35 Medical Use of Byproduct Material. | Discuss issues related to 10 CFR Part 35 Medical Use of Byproduct Material. | ||
Date and Time for Open Sessions: April 8, 2024, from 8:30 a.m. to 4:30 p.m. and April 9, 2024, from 10:00 a.m. to 12:00 p.m. Eastern Standard Time. | |||
Address for Public Meeting: U.S. Nuclear Regulatory Commission, One White Flint North Building (Commissioners Hearing Room, O1-F16/O1-G16), 11555 Rockville Pike, Rockville, Maryland, 20852. | |||
Date Webinar Information (Microsoft Teams) | Date Webinar Information (Microsoft Teams) | ||
April 8, 2024 Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_NjllNmZkODktZTg3My00MDU0LTk4NzMtNjRhN mJlYmRmNGY1%40thread.v2/0?context=%7b%22Tid%22%3a%22e8 d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%22304f46bf-32c2-4e0f-912c-878db895e74a%22%7d Meeting ID: 257 264 946 630 Passcode: n3TZmR Call in number (audio only): +301-576-2978, Silver Spring Phone Conference ID: 954 210 683# | |||
April 8, 2024 Link: https://teams.microsoft.com/l/meetup-join/19% | PUBLIC PARTICIPATION: The meeting will be held in-person and as a webinar using Microsoft Teams. Any member of the public who wishes to participate in the meeting in person, via Microsoft Teams, or via phone should contact Ms. L. Armstead using the information below. | ||
Members of the public should also monitor the NRCs Public Meeting Schedule at https://www.nrc.gov/pmns/mtg for any meeting updates. | |||
Meeting ID: 257 264 946 630 Passcode: n3TZmR | |||
Call in number (audio only): +301-576-2978, Silver Spring | |||
Phone Conference ID: 954 210 683# | |||
PUBLIC PARTICIPATION: The meeting will be held in-person and as a webinar using | |||
Microsoft Teams. Any member of the public who wishes to participate in the meeting in person, | |||
via Microsoft Teams, or via phone should contact Ms. L. Armstead using the information below. | |||
Members of the public should also monitor the NRCs Public Meeting Schedule at | |||
https://www.nrc.gov/pmns/mtg for any meeting updates. | |||
CONTACT INFORMATION: Ms. L. Armstead, e-mail: lxa5@nrc.gov, telephone: 301-415-1650. | CONTACT INFORMATION: Ms. L. Armstead, e-mail: lxa5@nrc.gov, telephone: 301-415-1650. | ||
Conduct of the Meeting The ACMUI Chair, Hossein Jadvar, M.D., Ph.D., will preside over the meeting. Dr. Jadvar will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: | |||
Conduct of the Meeting | |||
The ACMUI Chair, Hossein Jadvar, M.D., Ph.D., | |||
conduct the meeting in a manner that will facilitate the orderly conduct of business. The | |||
following procedures apply to public participation in the meeting: | |||
: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. | : 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. | ||
L. Armstead using the contact information listed above. All submittals must be received by the close of business on April 2, 2024, and must only pertain to the topics on the agenda. | |||
L. Armstead using the contact information listed above. All submittals must be received | : 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the ACMUI Chair. | ||
: 3. The draft transcript and meeting summary will be available on ACMUIs website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html on or about May 24, 2024. | |||
by the close of business on April 2, 2024, and must only pertain to the topics on the | : 4. Persons who require special services, such as those for the hearing impaired, should notify Ms. L. Armstead of their planned participation. | ||
This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commissions regulations in Title 10 of the Code of Federal Regulations, Part 7. | |||
agenda. | Dated at Rockville, Maryland this 4th day of March, 2024. | ||
: 2. Questions and comments from members of the public will be permitted during the | |||
meeting, at the discretion of the ACMUI Chair. | |||
: 3. The draft transcript and meeting summary will be available on ACMUIs website | |||
https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html on or about | |||
May 24, 2024. | |||
: 4. Persons who require special services, such as those for the hearing impaired, should | |||
notify Ms. L. Armstead of their planned participation. | |||
This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended | |||
(primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the | |||
Commissions regulations in Title 10 of the Code of Federal Regulations, Part 7. | |||
Dated at Rockville, Maryland this | |||
For the U.S. Nuclear Regulatory Commission. | For the U.S. Nuclear Regulatory Commission. | ||
Russell E. Chazell, Federal Advisory Committee Management Officer. | |||
Russell E. Chazell, Federal Advisory Committee Management Officer.}} | RUSSELL CHAZELL Digitally signed by RUSSELL CHAZELL Date: 2024.03.04 09:13:52 -05'00'}} | ||
Latest revision as of 19:52, 24 November 2024
| ML24061A227 | |
| Person / Time | |
|---|---|
| Issue date: | 03/04/2024 |
| From: | Russell Chazell NRC/SECY/RAS |
| To: | |
| References | |
| FR Citation: 89 FR 16590-16591; 03-07-24 | |
| Download: ML24061A227 (1) | |
Text
[7590-01-P]
NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice AGENCY: U.S. Nuclear Regulatory Commission ACTION: Notice of Meeting.
SUMMARY
- The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April 8 - 9, 2024. A sample of agenda items to be discussed include: a review of recent medical events; a review of prescription error reduction methods; and a review of several NRC draft licensing guidance documents for the Eye90 microsphere device, the Akesis Galaxy RTi unit, and the LV Liberty Vision Y-90 episcleral brachytherapy source. The agenda is subject to change. The current agenda and any updates will be available on the ACMUIs Meetings and Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html or by e-mailing Ms. L. Armstead at the contact information below.
Purpose:
Discuss issues related to 10 CFR Part 35 Medical Use of Byproduct Material.
Date and Time for Open Sessions: April 8, 2024, from 8:30 a.m. to 4:30 p.m. and April 9, 2024, from 10:00 a.m. to 12:00 p.m. Eastern Standard Time.
Address for Public Meeting: U.S. Nuclear Regulatory Commission, One White Flint North Building (Commissioners Hearing Room, O1-F16/O1-G16), 11555 Rockville Pike, Rockville, Maryland, 20852.
Date Webinar Information (Microsoft Teams)
April 8, 2024 Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_NjllNmZkODktZTg3My00MDU0LTk4NzMtNjRhN mJlYmRmNGY1%40thread.v2/0?context=%7b%22Tid%22%3a%22e8 d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%22304f46bf-32c2-4e0f-912c-878db895e74a%22%7d Meeting ID: 257 264 946 630 Passcode: n3TZmR Call in number (audio only): +301-576-2978, Silver Spring Phone Conference ID: 954 210 683#
PUBLIC PARTICIPATION: The meeting will be held in-person and as a webinar using Microsoft Teams. Any member of the public who wishes to participate in the meeting in person, via Microsoft Teams, or via phone should contact Ms. L. Armstead using the information below.
Members of the public should also monitor the NRCs Public Meeting Schedule at https://www.nrc.gov/pmns/mtg for any meeting updates.
CONTACT INFORMATION: Ms. L. Armstead, e-mail: lxa5@nrc.gov, telephone: 301-415-1650.
Conduct of the Meeting The ACMUI Chair, Hossein Jadvar, M.D., Ph.D., will preside over the meeting. Dr. Jadvar will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting:
- 1. Persons who wish to provide a written statement should submit an electronic copy to Ms.
L. Armstead using the contact information listed above. All submittals must be received by the close of business on April 2, 2024, and must only pertain to the topics on the agenda.
- 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the ACMUI Chair.
- 3. The draft transcript and meeting summary will be available on ACMUIs website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html on or about May 24, 2024.
- 4. Persons who require special services, such as those for the hearing impaired, should notify Ms. L. Armstead of their planned participation.
This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commissions regulations in Title 10 of the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland this 4th day of March, 2024.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell, Federal Advisory Committee Management Officer.
RUSSELL CHAZELL Digitally signed by RUSSELL CHAZELL Date: 2024.03.04 09:13:52 -05'00'